# Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)

> **NCT04441684** · NA · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 1466 (actual)

## Conditions studied

- SARS-CoV-2 Serological Status
- SARS-CoV-2 Seroprevalence

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample for serological test

## Key facts

- **NCT ID:** NCT04441684
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-17
- **Primary completion:** 2020-05-07
- **Final completion:** 2021-07-16
- **Target enrollment:** 1466 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441684, "Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04441684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*